BobbieJoRimelMD(She/Her)

PubMed

• 130 citations
  Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platin...
  Joyce F. Liu, William T. Barry, Michael J. Birrer, J.-M. Lee, Ronald J. Buckanovich
  Annals of Oncology. 2019-04-01
• 431 citations
  Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
  Joyce F. Liu, William T. Barry, Michael J. Birrer, Jung-Min Lee, Ronald J. Buckanovich
  The Lancet. Oncology. 2014-10-01
• 95 citations
  PARP Inhibition in Cancer: An Update on Clinical Development
  Esha Sachdev, Roya Tabatabai, Varun Roy, Bobbie J. Rimel, Monica M. Mita
  Targeted Oncology. 2019-12-01

Journal Articles

• Thrombocytosis at Secondary Cytoreduction for Recurrent Ovarian Cancer Predicts Suboptimal Resection and Poor Survival  
  Cohen JG, Tran A, Rimel, BJ, Cass I, Walsh CS, Karlan BY, Li A, Gynecol Oncol, 1/1/2014
• Post treatment surveillance of type II endometrial cancer patients  
  Zakhour M, Li AJ, Walsh CS, Cass, I, Karlan BY, Rimel BJ, Gynecol Oncol, 12/1/2013
• A Cost Analysis of Colposcopy following Abnormal Cytology in Post Treatment Cancer Surveillance for Cervical Cancer  
  Tergas A, Havrilesky L, Guntupalli S, Huh W, Massad L, Nickles-Fader A, Rimel BJ, Gynecol Oncol, 9/1/2013
• Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment  
  Rimel BJ, Ferda A, Erwin J, Dewdney S, Seamon, Gao F, DeSimone C, Cotney K, Huh W, Massad LS, Obstet Gynecol, 9/1/2011
• Inferior vena cava filter placement in the gynecologic oncology patient: A fifteen year institutional experience  
  Dewdney SB, Benn, T, Rimel BJ, Gao F, Saad N, Vedanthan S, Mutch DG, Zighelboim I, Gynecol Oncol, 5/1/2011
• Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 RSK4 in endometrial cancers  
  Dewdney SB, Rimel BJ, Thaker P, Thompson D, Schmidt A, Huettner P, Mutch D, Gao F, Goodfellow PJ, Clinical Cancer Research, 4/7/2011
• The role of neoadjuvant chemotherapy in the management of patients with advanced ovarian cancer: Survey results from the members of the Society of Gynecologic Oncologists  
  Dewdney SB, Rimel BJ, Reinhart AJ, Kizer NT, Brooks RA, Massad LS, Zighelboim I, Gynecol Oncol, 10/1/2010
• Absence of MGMT promoter methylation in endometrial cancer  
  Rimel BJ, Huettner P, Powell M, Mutch D, Goodfellow PJ, Gynecol Oncol, 7/1/2010
• Discussion: 'Biomarkers for detection of early ovarian cancer' by Nosov et al  
  Massad LS, Parks L, Rimel BJ, Kizer N, Ogutha J, Amer J Obstet Gynecol, 6/1/2009
• Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium  
  Rodriguez GC, Rimel BJ, Watkin W, Turbov JM, Barry C, Du H, Maxwell GL, Cline JM, Cancer Epidemiol Biomarkers Prev, 3/1/2008
• Update: Endometrial Cancer  
  Rimel BJ, Mutch D, OBG Management, 1/1/2008
• Cancer of the cervix: current management and new approaches  
  Shivnani AT, Rimel BJ, Schink J, Small W Jr, Oncology, 1/1/2006
• Lentivirus vectors using human and simian immunodeficiency virus elements  
  White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JD, Planelles V, J Virol, 1/1/1999
• Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr  
  Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, Nguyen D, Rosenblatt JD, Planelles V, Exp Cell Res, 1/1/1999
• Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein  
  Challita-Eid PM, Klimatcheva E, Day BT, Evans T, Dreyer K, Rimel BJ, Rosenblatt JD, Planelles V, AIDS Res Hum Retroviruses, 1/1/1998
• Join now to see all